Werbung
Werbung

AKTX

AKTX logo

Akari Therapeutics plc ADR (0.01 USD)

0.28
USD
Gesponsert
0.00
+0.92%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

0.29

+0.01
+1.75%

AKTX Ergebnisberichte

Positives Überraschungsverhältnis

AKTX übertreffen die 8 der letzten 17Schätzungen.

47%

Nächster Bericht

Datum des nächsten Berichts
13. Apr. 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.06
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
--

Akari Therapeutics plc ADR (0.01 USD) earnings per share and revenue

On 13. Nov. 2025, AKTX reported earnings of 0.00 USD per share (EPS) for Q3 25, beating the estimate of -0.07 USD, resulting in a 100.00% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.67% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.06 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, Akari Therapeutics plc ADR (0.01 USD) reported EPS of $0.00, beating estimates by 100%, and revenue of $0.00, 0% as expectations.
The stock price moved up 1.67%, changed from $0.52 before the earnings release to $0.53 the day after.
The next earning report is scheduled for 13. Apr. 2026.
Based on 5 analysts, Akari Therapeutics plc ADR (0.01 USD) is expected to report EPS of -$0.06 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung